Skip to main content

Lansing Taylor, Jorgine Ellerbrock

Premium
The Pittsburgh Life Sciences Greenhouse has named Lansing Taylor as its chairman.
 
Taylor takes over for Co-chairs Mark Nordenberg and Jared Cohon.
 
He is already on the board of PLSG and recently served as chairman and CEO of high-content cell screening firm Cellomics, which he founded and was acquired by Thermo Fisher Scientific in September 2005. He also was a co-founder, member of the board, and scientific advisor to Biological Detection Systems, which was sold to Amersham Biosciences in 1996
 

 
Jorgine Ellerbrock has been named senior VP of operations at Gen-Probe.
 
Ellerbrock formerly was VP of operations at Invitrogen’s molecular biology business, and before that she was at GE Healthcare Biosciences, where she was VP of operations and VP of genomics product management. She also held various posts at Roche.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.